These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32455705)

  • 1. Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor.
    Kim SI; Kang N; Leem S; Yang J; Jo H; Lee M; Kim HS; Dhanasekaran DN; Kim YK; Park T; Song YS
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study.
    Yang J; McDowell A; Seo H; Kim S; Min TK; Jee YK; Choi Y; Park HS; Pyun BY; Kim YK
    Allergy Asthma Immunol Res; 2020 Sep; 12(5):792-805. PubMed ID: 32638560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of diagnostic utility of multivariate diagnostic models in differential diagnosis of ovarian tumors.
    Horała A; Swiatly A; Lorek J; Kokot ZJ; Matysiak J; Nowak-Markwitz E
    Ginekol Pol; 2018; 89(10):568-572. PubMed ID: 30393846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy.
    Lee SW; Lee HY; Bang HJ; Song HJ; Kong SW; Kim YM
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteria-Derived Extracellular Vesicles in Urine as a Novel Biomarker for Gastric Cancer: Integration of Liquid Biopsy and Metagenome Analysis.
    Park JY; Kang CS; Seo HC; Shin JC; Kym SM; Park YS; Shin TS; Kim JG; Kim YK
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.
    Miao R; Badger TC; Groesch K; Diaz-Sylvester PL; Wilson T; Ghareeb A; Martin JA; Cregger M; Welge M; Bushell C; Auvil L; Zhu R; Brard L; Braundmeier-Fleming A
    PLoS One; 2020; 15(1):e0227707. PubMed ID: 31917801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer.
    Lai H; Guo Y; Tian L; Wu L; Li X; Yang Z; Chen S; Ren Y; He S; He W; Yang G
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16S rRNA gene-based metagenomic analysis reveals differences in bacteria-derived extracellular vesicles in the urine of pregnant and non-pregnant women.
    Yoo JY; Rho M; You YA; Kwon EJ; Kim MH; Kym S; Jee YK; Kim YK; Kim YJ
    Exp Mol Med; 2016 Feb; 48(2):e208. PubMed ID: 26846451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis.
    Kim JR; Han K; Han Y; Kang N; Shin TS; Park HJ; Kim H; Kwon W; Lee S; Kim YK; Park T; Jang JY
    Biology (Basel); 2021 Mar; 10(3):. PubMed ID: 33805810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
    Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
    PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis.
    Cao L; Zhang Y; Fu Z; Dong L; Yang S; Meng W; Li Y; Zhang W; Zhang J; Zheng C; Zhu H; Fan L
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1951-8. PubMed ID: 26472266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting ovarian cancer using extracellular vesicles: progress and possibilities.
    Carollo E; Paris B; Samuel P; Pantazi P; Bartelli TF; Dias-Neto E; Brooks SA; Pink RC; Carter DRF
    Biochem Soc Trans; 2019 Feb; 47(1):295-304. PubMed ID: 30700499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.
    Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor diagnostic model and dietary effect based on extracellular vesicle microbiome data in serum.
    Yang J; Moon HE; Park HW; McDowell A; Shin TS; Jee YK; Kym S; Paek SH; Kim YK
    Exp Mol Med; 2020 Sep; 52(9):1602-1613. PubMed ID: 32939014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the detection of ovarian cancer.
    Høgdall E
    Scand J Clin Lab Invest Suppl; 2016; 245():S49-53. PubMed ID: 27435369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.